First Symptoms of Measles You Can't Ignore

Measles is a highly contagious viral disease caused by the Morbillivirus genus, characterized by fever, cough, runny nose, conjunctivitis, and a distinctive red rash. It can lead to severe complications like pneumonia and encephalitis, and remains a significant public health concern. The MMR (measles, mumps, rubella) vaccine is the most effective prevention, with two doses providing 97% protection.

Last updated: July 2025 — Updated with 2025 outbreak data, booster recommendations, and expanded complication details.

What Is Measles?

Measles is a highly contagious viral disease caused by the Morbillivirus genus, characterized by fever, cough, runny nose, conjunctivitis, and a red rash. It can cause serious complications like pneumonia (the most common cause of death from measles) and encephalitis. According to the World Health Organization (WHO, 2024), measles remains a leading cause of vaccine-preventable death among children globally, with an estimated 136,000 deaths in 2022. Vaccination with the MMR vaccine is the most effective prevention, with two doses providing 97% protection against the virus. The U.S. Centers for Disease Control and Prevention (CDC, 2025) corroborates this protection rate, noting that the MMR vaccine is a live attenuated vaccine that has been in use since 1971.

What Are the First Symptoms of Measles?

The first symptoms of measles appear 7-14 days after exposure and include high fever (often exceeding 104°F), cough, runny nose, and red, watery eyes (conjunctivitis). A red rash appears 3-5 days after these initial symptoms, starting on the face at the hairline and spreading downward to the trunk and limbs. Koplik spots—tiny white spots with bluish-white centers inside the mouth—are a pathognomonic sign that appears 1-2 days before the rash. According to the U.S. Centers for Disease Control and Prevention (CDC, 2025), these early symptoms are often mistaken for a cold or flu, delaying diagnosis and increasing transmission risk. The American Academy of Pediatrics (AAP, 2024) emphasizes that the presence of Koplik spots is a definitive diagnostic indicator that distinguishes measles from other viral exanthems.

How Is Measles Transmitted?

Measles spreads through respiratory droplets when an infected person coughs or sneezes. The virus can remain infectious in the air for up to two hours after an infected person leaves a room, making it one of the most contagious known pathogens. According to the CDC (2025), a 90% infection rate occurs among non-immune close contacts. The virus can also survive on surfaces for several hours. Measles is contagious from four days before the rash appears to four days after, meaning transmission can occur before symptoms are noticeable. This high transmissibility is why measles outbreaks spread rapidly in under-vaccinated communities. The WHO (2024) reports that the basic reproduction number (R0) for measles is 12-18, meaning one infected person can infect 12-18 others in a susceptible population.

What Are the Complications of Measles?

Measles can cause severe complications, particularly in children under 5, adults over 20, and immunocompromised individuals. According to the WHO (2024), common complications include pneumonia (the leading cause of death from measles), encephalitis (brain swelling that can cause permanent brain damage), and severe diarrhea leading to dehydration. A rare but fatal complication called subacute sclerosing panencephalitis (SSPE) can develop 7-10 years after infection. The CDC (2025) reports that about 1 in 5 unvaccinated people with measles in the U.S. are hospitalized, and 1 in 1,000 develop encephalitis. Pregnant women face increased risk of miscarriage and preterm birth. The National Institutes of Health (NIH, 2025) adds that measles can cause “immune amnesia,” where the virus erases the immune system’s memory of previous infections, leaving survivors vulnerable to other diseases for months to years.

How Is Measles Treated?

There is no specific antiviral treatment for measles. Care is supportive, including rest, fluids, and fever management with acetaminophen or ibuprofen. According to the WHO (2024), vitamin A supplements (200,000 IU for children over 12 months) can reduce the severity of the disease and the risk of complications, particularly in malnourished populations. The CDC (2025) recommends vitamin A for all children with measles, given in two doses 24 hours apart. Hospitalization may be required for severe cases, especially those with pneumonia or encephalitis. Antibiotics are used only if secondary bacterial infections develop. The American Academy of Family Physicians (AAFP, 2025) notes that ribavirin has been used experimentally in severe cases but is not FDA-approved for measles treatment.

Measles vs. Other Rash-Causing Illnesses: A Comparison

Feature	Measles	Rubella (German Measles)	Roseola	Fifth Disease
Causative agent	Measles virus (Morbillivirus)	Rubella virus (Rubivirus)	Human herpesvirus 6 (HHV-6)	Parvovirus B19
Fever pattern	High fever (104°F+) before rash	Mild fever (101°F)	High fever (103°F) for 3-5 days, then rash	Mild fever (101°F)
Rash appearance	Red, blotchy, starts on face, spreads downward	Pink, fine, starts on face, spreads quickly	Rose-pink spots on trunk, spreads to limbs	”Slapped cheek” rash on face, lacy rash on body
Koplik spots	Present (pathognomonic)	Absent	Absent	Absent
Contagious period	4 days before to 4 days after rash	7 days before to 7 days after rash	During fever, not after rash	Before rash appears
Vaccine available	Yes (MMR)	Yes (MMR)	No	No
Complication risk	High (pneumonia, encephalitis)	Low (except in pregnancy)	Very low	Low (except in pregnancy)

What Is the Measles Vaccine?

The measles vaccine is part of the MMR (measles, mumps, rubella) combination vaccine. According to the CDC (2025), two doses of MMR vaccine are 97% effective at preventing measles, while one dose is 93% effective. The first dose is recommended at 12-15 months of age, and the second at 4-6 years. The MMRV vaccine (which also includes varicella) is an alternative for children aged 12 months to 12 years. The vaccine contains live attenuated viruses and is contraindicated in pregnant women and severely immunocompromised individuals. According to the WHO (2024), global measles vaccination coverage reached 83% for the first dose in 2022, but only 74% for the second dose, well below the 95% threshold needed for herd immunity. The Global Vaccine Action Plan (GVAP, 2025) targets 90% coverage for both doses by 2030.

Do Adults Need a Measles Booster?

Adults born after 1957 who have not been vaccinated or had measles should receive at least one dose of MMR. According to the CDC (2025), adults at higher risk—including healthcare workers, international travelers, students in post-secondary institutions, and those living in outbreak areas—should receive two doses of MMR, given 28 days apart. The CDC also recommends that adults born before 1957 are generally considered immune due to likely prior infection. In 2025, with measles outbreaks reported in multiple U.S. states and Canada, the CDC has emphasized that adults unsure of their vaccination status should get a booster. A blood test (titer) can confirm immunity. The Infectious Diseases Society of America (IDSA, 2025) recommends that healthcare workers born before 1957 who cannot document immunity should also receive two doses of MMR.

What Is the Measles Death Rate?

The measles death rate varies significantly by region and access to healthcare. According to the WHO (2024), the global case fatality rate is approximately 1-3 per 1,000 cases in developed countries, but can reach 10-30% in humanitarian crises and malnourished populations. In the United States, the CDC (2025) reports a case fatality rate of about 1-2 per 1,000 cases, with most deaths occurring in children under 5. In 2022, an estimated 136,000 measles deaths occurred globally, mostly among children under 5. The death rate is highest in regions with low vaccination coverage, such as parts of Africa and Southeast Asia. The WHO (2024) notes that measles mortality has declined by 73% globally since 2000, largely due to increased vaccination efforts.

How Long Is Measles Contagious?

A person with measles is contagious from four days before the rash appears to four days after the rash appears. According to the CDC (2025), the virus can be transmitted even before symptoms are noticeable, making early isolation challenging. The virus remains infectious in the air for up to two hours after an infected person leaves a room. Healthcare workers and caregivers should use N95 respirators and practice strict isolation precautions. The contagious period is one reason measles spreads so rapidly in communities with low vaccination rates. The WHO (2024) recommends that exposed individuals who are not immune should be quarantined for 21 days after the last exposure.

Measles Outbreak 2025: What You Need to Know

In 2025, measles outbreaks have been reported in multiple U.S. states, including Texas, Ohio, and New York, as well as in Ontario, Canada. According to the CDC (2025), as of July 2025, there have been over 500 confirmed cases in the U.S., compared to 285 cases in all of 2024. The outbreaks are concentrated in communities with vaccination rates below 90%. The Public Health Agency of Canada (PHAC, 2025) reports 150 cases in Ontario, primarily in unvaccinated individuals. The WHO (2024) warns that global measles cases increased by 20% in 2024 compared to 2023, driven by pandemic-related vaccination gaps.

Can You Get Measles If You Are Vaccinated?

Breakthrough infections can occur in vaccinated individuals, but they are rare and typically milder. According to the CDC (2025), two doses of MMR vaccine are 97% effective, meaning about 3% of fully vaccinated people may still get measles if exposed. However, vaccinated individuals who contract measles are less likely to develop severe complications or transmit the virus. The WHO (2024) notes that breakthrough infections are more common in settings with high viral load, such as household exposure. The National Institute of Allergy and Infectious Diseases (NIAID, 2025) explains that waning immunity over time is possible but rare, and booster doses are not routinely recommended for the general population.

How Is Measles Diagnosed?

Measles is diagnosed through a combination of clinical presentation and laboratory testing. According to the CDC (2025), a blood test for measles-specific IgM antibodies is the standard diagnostic method, with samples collected within 3-28 days of rash onset. A throat swab or urine sample can also be tested for measles virus RNA using reverse transcription polymerase chain reaction (RT-PCR). The WHO (2024) recommends that all suspected measles cases be confirmed by laboratory testing to support outbreak surveillance. The Association of Public Health Laboratories (APHL, 2025) emphasizes that rapid diagnosis is critical for implementing control measures and preventing further spread.

What Is the Incubation Period for Measles?

The incubation period for measles is typically 7-14 days from exposure to the onset of symptoms. According to the CDC (2025), the average incubation period is 10-12 days, with the rash appearing approximately 14 days after exposure. The WHO (2024) notes that the incubation period can extend up to 21 days in some cases, particularly in immunocompromised individuals. This long incubation period, combined with the contagious period before symptoms appear, makes measles difficult to contain through symptom-based screening alone.